How to optimize patient safety and care coordination in clinical trials?

Increasing patients’ safety and care in research is vital when preparing and conducting your study. From a HEMEX perspective, we are tackling in this article four important points you should consider during the process.

Progress too slow for equality in science

February 11 is commemorated worldwide as the International Day of Women and Girls in Science by the United Nations General Assembly. Unfortunately, there is still a significant gender gap at all levels of science, technology, engineering, and mathematics (STEM) disciplines all over the world. At HEMEX, we ask ourselves, how is this still happening in the middle of the Fourth Industrial Revolution?

Phagomed Acquired By BioNTech SE

The Austrian biotech company is developing endolysins and phages as therapeutics, focusing on persistent bacterial infections that cannot be targeted with broad-spectrum antibiotics. This acquisition is a big step for the AMR crisis and the formerly Phagomed team. At HEMEX, we wanted to congratulate them on their fantastic job!

Comms&Media service for startups powered by Benz Advisory, mediacrewgroup, and HEMEX

Benz Advisory, mediacrewgroup, and HEMEX join forces to support early-stage companies with strategic communications through a new service called Comms&Media. Targeted at early-stage businesses from all industries, it offers a unique, holistic approach to help companies develop and implement effective external and internal communications.

Major milestone for Inura Medical, who closes pre-series A financing round

Inura Medical’s mission is to improve women’s health through the development of an urethral ovulum for the treatment of patients suffering from urinary bladder diseases. Their first pharmaceutical product is addressing an unmet medical need in overactive bladder (OAB).